FDA MedWatch News FDA Warnings
 
Ennis & Ennis, P.A. is a national law firm that specializes in mass torts, defective medical devices and product liablity cases. If you have been injured you need to know your legal rights. Contact the lawyers of Ennis & Ennis today for a free case evaluation.
Ennis & Ennis, P.A. News
Free Case Evaluation

FDA MedWatch

Innohep (tinzaparin sodium) Dear Healthcare Professional Letter issued re: increased risk of death in renal impaired elderly

Innohep (tinzaparin sodium injection)

Audience: Hematological and Nephrological healthcare professionals, hospital risk managers

12/31/2008- Celgene has issued a Dear Healthcare Professional letter describing a controlled clinical study suggesting that Innohep may increase the risk for death, compared to unfractionated heparin when used to treat elderly patients with renal insufficiency. It recommended consideration of alternatives to Innohep when treating these patients for deep vein thrombosis with or without pulmonary embolism.

Read the complete MedWatch 2008 Safety summary, including a link to the Dear Healthcare Professional letter and the December 2 FDA Ongoing Safety Review, at:

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Innohep

 

 

 

 

 

 

 

 

 
Required fields in yellow
 
Name:
Email:
 
Telephone: (123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
Please List Defective Product You Are Inquiring About:
Please List Any Side Effects, Injuries, or Property Damage:
Additional Information:
 
 

 

 
Nationwide Free Case Evaluations: 1-800-856-6405